Facilitated By

San Antonio Medical Foundation

News

  • Stocks are mostly lower on Wall Street with trade in focus

    Merck is spending $2.7 billion for ArQule, a small biotechnology company that is still in the earlier stages of studying potential treatments for conditions ...

  • New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium

    New Menarini CELLSEARCH Studies to be Presented at San Antonio .... biotechnology and diagnostics company headquartered in Florence, Italy, ...

  • Researchers identify top ways to stop projected 142% rise in Latino cancer

    26-28, 2020, in San Antonio, is open for registration. ... nursing, dentistry, health professions and graduate biomedical sciences have produced 36,500 ...

  • ArQule and Fate Therapeutics soar; Sanofi and Diplomat fall

    The drug developer is buying biotechnology firm Synthorx, which focuses on potential cancer treatments, for $2.5 billion. ArQule Inc., up $10.04 to ...

  • Lab worker caught a deadly rare virus – from a research monkey

    Mr Lee, of San Antonio, , was struck down with it while working at Texas Biomedical Research Institute, where 2,500 primates are tested for research ...